Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endomet...
Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany
About this item
Full title
Publisher
Ottawa: PR Newswire Association LLC
Journal title
Language
English
Formats
Publication information
Publisher
Ottawa: PR Newswire Association LLC
Subjects
More information
Scope and Contents
Contents
"The safety and efficacy of AEZS-108 in our study on advanced endometrial cancer was very encouraging," commented Prof. [Gunter Emons]. "We must keep in mind that we used AEZS-108 as a single agent treatment only, and still achieved good rates of objective response and disease stabilization. Importantly from the patients' point of view, overall sur...
Alternative Titles
Full title
Aeterna Zentaris Presents Positive Phase 2 Efficacy and Safety Data for AEZS-108 in Advanced Endometrial Cancer at ENA Meeting in Berlin, Germany
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_799502950
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_799502950
